Accelerate Diagnostics Inc expected to post a loss of 25  cents a share - Earnings Preview

Accelerate Diagnostics

05/03/2022 01:45

* Accelerate Diagnostics Inc  AXDX.OQ   AXDX.O  is expected
to show a rise in quarterly revenue when it reports  results on
March 8. 
    * The Tucson Arizona-based  company is expected to report  a
19.0% increase in revenue to $3.7 million from $3.11 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Accelerate
Diagnostics
Inc is for a loss of 25 cents per share. For the same quarter
last year, the company reported a loss of 33 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $9​, about 74% above​ its last closing price
of $2.34. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.34       -0.33      -0.15     Beat    54.3
 Jun. 30 2021  -0.34       -0.33      -0.36     Missed  -9.1
 Mar. 31 2021  -0.34       -0.33      -0.41     Missed  -24.2​
 Dec. 31 2020  -0.32       -0.32      -0.33     Missed  -2.5
 ​​Sep.        -0.33       -0.33      -0.33     Met     1.2
 30 2020                                                
 Jun. 30 2020  -0.34       -0.34      -0.35     Missed  -2.9​
 Mar. 31 2020  -0.39       -0.38      -0.39     Missed  -1.3
 Dec. 31 2019  -0.40       -0.40      -0.39     Beat    3.7
 This summary was machine generated March 5 at 01:45 GMT.  All
figures in US dollars  unless otherwise stated